Ludwig Maximilian University of Munich

DGAP-News: Dr Cornelius Baur appointed as new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA

Retrieved on: 
Friday, May 13, 2022 - 2:13pm

DGAP-News: CTS Eventim AG & Co. KGaA

Key Points: 
  • DGAP-News: CTS Eventim AG & Co. KGaA
    Dr Cornelius Baur appointed as new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA
    The issuer is solely responsible for the content of this announcement.
  • Dr Cornelius Baur appointed as new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA
    Munich, 13 May 2022.
  • Dr Cornelius Baur has been appointed as the new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA.
  • Dr Bernd Kundrun, Chairman of the Supervisory Board, emphasised: I am delighted that we were able to win Dr Baur for this role.

Martin Wiedmann Announced as the 2022 Borlaug CAST Communication Award Winner

Retrieved on: 
Tuesday, May 10, 2022 - 6:30pm

AMES, Iowa, May 10, 2022 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology (CAST) has announced the 2022 Borlaug CAST Communication Award goes to Dr. Martin Wiedmann, Gellert Family Professor of Food Safety, Department of Food Science in the College of Agriculture and Life Sciences at Cornell University. He is currently an associate director at the Northeast Dairy Foods Research Center at Cornell University and co-director at the New York Integrated Food Safety Center of Excellence.

Key Points: 
  • The Council for Agricultural Science and Technology (CAST) has announced the 2022 Borlaug CAST Communication Award goes to Dr. Martin Wiedmann.
  • AMES, Iowa, May 10, 2022 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology (CAST) has announced the 2022 Borlaug CAST Communication Award goes to Dr. Martin Wiedmann, Gellert Family Professor of Food Safety, Department of Food Science in the College of Agriculture and Life Sciences at Cornell University.
  • It has also been said that Wiedmann has the gift of communicating technical information to non-technical audiences.
  • The Borlaug CAST Communication Award honors the legacy of Dr. Norman Borlaug, a Nobel Prize winner and author of the first CAST publication, and Dr. Charles A.

Fewer scientists, more skepticism of science in states that limit evolution instruction

Retrieved on: 
Wednesday, April 6, 2022 - 5:55pm

These findings are of further interest as the U.S. enters the third year of a deadly pandemic amid public distrust of science and vaccinations.

Key Points: 
  • These findings are of further interest as the U.S. enters the third year of a deadly pandemic amid public distrust of science and vaccinations.
  • Arold looked at the impact of changes in how state science standards covered the topic of evolution between 2000 and 2009, when two thirds of U.S. states revised the evolution coverage of their science standards.
  • In states that require comprehensive evolution instruction in high school, students correctly answer more questions about evolution on the 12th-grade science NAEP exam.
  • When state education leaders require comprehensive instruction in evolution theory in high school, they are helping grow the science workforce of the future.

Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personalized Cancer Immunotherapies

Retrieved on: 
Wednesday, April 6, 2022 - 12:30pm

COPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (Evaxion or the Company), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced today that it will host a key opinion leader (KOL) webinar with a focus on personalized cancer immunotherapies and melanoma treatment options on Tuesday, April 12, 2022 at 12:30 pm ET.

Key Points: 
  • COPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (Evaxion or the Company), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced today that it will host a key opinion leader (KOL) webinar with a focus on personalized cancer immunotherapies and melanoma treatment options on Tuesday, April 12, 2022 at 12:30 pm ET.
  • The webinar will feature a presentation from Key Opinion Leaders (KOLs)Jeffrey S. Weber MD, PhD(NYU-Grossman School of Medicine)andPatrick Ott, MD, PhD (Dana Farber Cancer Institute).Dr.
  • Weber will discuss the current treatment landscape and unmet medical needs in patients with metastatic melanoma.
  • Dr. Ott will then discuss the role and potential of personalized cancer immunotherapies.

HMNC Brain Health Appoints Dr. Bertram Müller-Myhsok as Head of Precision Psychiatry

Retrieved on: 
Thursday, February 24, 2022 - 1:30pm

MUNICH, Germany, Feb. 24, 2022 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC'' or the “Company”), a clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced today the appointment of Dr. Bertram Müller-Myhsok as its new Head of Precision Psychiatry, effective March 1, 2022. The Head of the Statistical Genetics Research Group at Max-Planck-Institute of Psychiatry in Munich has signed an additional contract with HMNC Brain Health next to his position at the Max-Planck-Institute. In his new role, Dr. Müller-Myhsok will help the Company to accelerate the development of differentiated treatment options through the combination of novel interventions with precision applications.

Key Points: 
  • MUNICH, Germany, Feb. 24, 2022 (GLOBE NEWSWIRE) -- HMNC Brain Health (HMNC'' or the Company), a clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced today the appointment of Dr. Bertram Mller-Myhsok as its new Head of Precision Psychiatry, effective March 1, 2022.
  • The Head of the Statistical Genetics Research Group at Max-Planck-Institute of Psychiatry in Munich has signed an additional contract with HMNC Brain Health next to his position at the Max-Planck-Institute.
  • As Head of Precision Psychiatry, Dr. Mller-Myhsoks decades of experience in human genetics research will allow HMNC Brain Health to advance its work utilizing genetic analyses and artificial intelligence to better detect the underlying genetic or physiological causes of disorders in specific individuals and develop personalized therapies for neuropsychiatric disorders.
  • HMNC Brain Health (HMNC Holding GmbH) is a global precision psychiatry biopharma company pioneering the development of personalized therapies powered by predictive companion diagnostics, leading to far shorter treatments and higher remission rates.

DGAP-News: Stabilus S.A.: Annual General Meeting approves a dividend of €1.25 per share and elects Inka Koljonen as new member of the Supervisory Board

Retrieved on: 
Thursday, February 17, 2022 - 6:38pm

The company will thus pay a dividend for the 2021 fiscal year (which ended on September 30, 2021) of 1.25 per share (previous year: 0.50).

Key Points: 
  • The company will thus pay a dividend for the 2021 fiscal year (which ended on September 30, 2021) of 1.25 per share (previous year: 0.50).
  • This is equivalent to around 30.9 million and a distribution ratio of around 42% of the company's consolidated net income.
  • In addition, Inka Koljonen was elected as a new member of the Supervisory Board.
  • As a member of the Executive Board of MAN Truck & Bus SE, she has been responsible for Finance, IT and Legal Affairs since February 2022.

China and USA at the forefront of digitalisation, UK keeping pace despite Brexit

Retrieved on: 
Tuesday, February 15, 2022 - 11:44am

LUDWIGSBURG, Germany, Feb. 15, 2022 /PRNewswire/ -- An international comparison shows that Chinese and US companies are the frontrunners in the use of digital technologies in an Industry 4.0 environment. The United Kingdom, though slightly off the pace, is managing to keep up, due in some part to the early course set for Brexit. These are the key findings of the Industry 4.0 Barometer 2021, compiled by the management and IT consultancy MHP in cooperation with the Ludwig Maximilian University (LMU) Munich. 776 experts from industrial companies in Germany, Austria, Switzerland, China, the UK and the USA took part in the survey, which was conducted for the fourth time last year. The barometer shows the status quo of Industry 4.0 activities at the companies surveyed and provides insights into market-specific features in the regions studied.

Key Points: 
  • The United Kingdom, though slightly off the pace, is managing to keep up, due in some part to the early course set for Brexit.
  • 776 experts from industrial companies in Germany, Austria, Switzerland, China, the UK and the USA took part in the survey, which was conducted for the fourth time last year.
  • The barometer shows the status quo of Industry 4.0 activities at the companies surveyed and provides insights into market-specific features in the regions studied.
  • Internationally, a CIO in the management, customer focus and collaboration are proving to be universal guarantees of success," states Tom Huber.

China and USA at the forefront of digitalisation, UK keeping pace despite Brexit

Retrieved on: 
Tuesday, February 15, 2022 - 11:41am

The United Kingdom, though slightly off the pace, is managing to keep up, due in some part to the early course set for Brexit.

Key Points: 
  • The United Kingdom, though slightly off the pace, is managing to keep up, due in some part to the early course set for Brexit.
  • 776 experts from industrial companies in Germany, Austria, Switzerland, China, the UK and the USA took part in the survey, which was conducted for the fourth time last year.
  • The barometer shows the status quo of Industry 4.0 activities at the companies surveyed and provides insights into market-specific features in the regions studied.
  • Internationally, a CIO in the management, customer focus and collaboration are proving to be universal guarantees of success," states Tom Huber.

EUTOP founder Klemens Joos appointed honorary professor

Retrieved on: 
Friday, February 11, 2022 - 10:02am

MUNICH, Feb. 11, 2022 /PRNewswire/ -- The founder and Chairman of the Advisory Board of the governmental relations agency EUTOP, Dr Klemens Joos, has been appointed honorary professor for Political Stakeholder Management by the Technical University of Munich (TUM).

Key Points: 
  • MUNICH, Feb. 11, 2022 /PRNewswire/ -- The founder and Chairman of the Advisory Board of the governmental relations agency EUTOP, Dr Klemens Joos, has been appointed honorary professor for Political Stakeholder Management by the Technical University of Munich (TUM).
  • Dr Joos has been a visiting lecturer at the TUM School of Management since April 2021.
  • In parallel to his commitment, Dr Joos developed the original company EUTOP into today's EUXEA Group.
  • Dr Joos on his appointment to honorary professor at TUM: "I am very honoured.

EUTOP founder Klemens Joos appointed honorary professor

Retrieved on: 
Friday, February 11, 2022 - 9:56am

MUNICH, Feb. 11, 2022 /PRNewswire/ -- The founder and Chairman of the Advisory Board of the governmental relations agency EUTOP, Dr Klemens Joos, has been appointed honorary professor for Political Stakeholder Management by the Technical University of Munich (TUM).

Key Points: 
  • MUNICH, Feb. 11, 2022 /PRNewswire/ -- The founder and Chairman of the Advisory Board of the governmental relations agency EUTOP, Dr Klemens Joos, has been appointed honorary professor for Political Stakeholder Management by the Technical University of Munich (TUM).
  • Dr Joos has been a visiting lecturer at the TUM School of Management since April 2021.
  • In parallel to his commitment, Dr Joos developed the original company EUTOP into today's EUXEA Group.
  • Dr Joos on his appointment to honorary professor at TUM: "I am very honoured.